Albemarle Corporation $ALB Stock Acquired by Sumitomo Mitsui Trust Group Inc.

Posted by George Bondi on Nov 7th, 2026

Sumitomo Mitsui Trust Group Inc. grew its holdings in Albemarle Corporation (NYSE:ALB – Free Report) by 57.8% during the 3rd quarter, Holdings Channel reports. The fund owned 52,978 shares of the specialty chemicals company’s stock after buying an additional 19,399 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Albemarle were worth $5,604,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of ALB. Primecap Management Co. CA bought a new stake in shares of Albemarle during the 2nd quarter valued at $358,101,000. Deutsche Bank AG bought a new position in Albemarle in the 2nd quarter worth $131,049,000. Bank of New York Mellon Corp purchased a new position in Albemarle during the second quarter valued at $103,268,000. Robeco Institutional Asset Management B.V. lifted its position in Albemarle by 2,981.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 733,793 shares of the specialty chemicals company’s stock valued at $77,621,000 after purchasing an additional 709,977 shares in the last quarter. Finally, ProShare Advisors LLC lifted its position in Albemarle by 69.7% during the third quarter. ProShare Advisors LLC now owns 1,436,117 shares of the specialty chemicals company’s stock valued at $151,912,000 after purchasing an additional 589,787 shares in the last quarter. Hedge funds and other institutional investors own 92.87% of the company’s stock.

Albemarle Price Performance

Albemarle stock traded up $0.66 during mid-day trading on Friday, hitting $99.03. The stock had a trading volume of 2,444,312 shares, compared to its average volume of 2,458,542. Albemarle Corporation has a one year low of $89.77 and a one year high of $221.00. The company has a current ratio of 2.09, a quick ratio of 1.35 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $11.69 billion, a P/E ratio of 23.92, a P/E/G ratio of 0.54 and a beta of 1.34. The firm’s 50 day moving average is $107.59 and its 200 day moving average is $147.87.

Albemarle (NYSE:ALB – Get Free Report) last announced its quarterly earnings data on Wednesday, November 4th. The specialty chemicals company reported $2.58 EPS for the quarter, beating the consensus estimate of $2.53 by $0.05. The business had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.52 billion. Albemarle had a return on equity of 10.96% and a net margin of 3.09%. The business’s revenue was up 18.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.19) earnings per share. On average, sell-side analysts forecast that Albemarle Corporation will post 11.20 earnings per share for the current fiscal year.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Friday, December 18th will be paid a dividend of $0.41 per share. This represents a $1.64 annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend is Friday, December 18th. Albemarle’s dividend payout ratio (DPR) is 39.61%.

Analyst Upgrades and Downgrades

ALB has been the subject of a number of analyst reports. Zacks Research cut Albemarle from a “hold” rating to a “strong sell” rating in a research report on Friday, October 9th. Royal Bank Of Canada lowered their price objective on Albemarle from $129.00 to $119.00 and set an “outperform” rating on the stock in a research report on Friday. Weiss Ratings downgraded Albemarle from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, October 23rd. Scotiabank reduced their target price on shares of Albemarle from $200.00 to $190.00 and set a “sector outperform” rating for the company in a report on Monday, August 10th. Finally, Citigroup decreased their target price on shares of Albemarle from $175.00 to $125.00 and set a “buy” rating on the stock in a research note on Thursday, October 22nd. Fifteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $177.64.

Get Our Latest Stock Analysis on Albemarle

Albemarle News Roundup

Here are the key news stories impacting Albemarle this week:

Positive Sentiment: Albemarle reported third-quarter adjusted earnings of $2.58 per share, ahead of estimates, on $1.55 billion in revenue—also above forecasts and up 18.8% year over year. Higher lithium pricing, strong demand, cost reductions and improved Specialties profits supported the results. Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand
Positive Sentiment: Scotiabank maintained its “Sector Outperform” rating and $190 price target, estimating EPS of $11.64 for FY2026 and $14.15 for FY2027—above the cited current-year consensus estimate. Albemarle analyst coverage
Positive Sentiment: Truist reaffirmed its “buy” rating, though it lowered its price target to $170 from $185. Truist rating information
Neutral Sentiment: RBC cut its target to $119 from $129 but retained an “outperform” rating, reflecting a more cautious valuation alongside continued optimism about the shares. RBC rating information
Negative Sentiment: Barclays lowered its target to $95 from $109 and kept an “equal weight” rating, pointing to a less favorable near-term risk-reward view. Lithium prices remain volatile, a potential source of uncertainty for earnings. Barclays rating information

Albemarle Profile

(Free Report)

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.